BIOMAT Database Logo BIOMAT Database Logo

Bilateral Pretibial Edema Associated with Paliperidone Palmitate Long-acting Injectable: A Case Report. 2017

Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Department of Psychiatry, Çumra State Hospital, Konya, Turkey.

Peripheral edema is observed as an adverse effect of the usage of antipsychotics in the literature. This case report describes a 36-year-old female patient with the diagnosis of paranoid schizophrenia who presented with pretibial edema following initiation of long-acting injectable paliperidone palmitate. Pretibial edema developed within the second week of treatment and completely disappeared after its discontinuation.

UI MeSH Term Description Entries

Related Publications

Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate: A Case Report.
December 2017, Journal of clinical psychopharmacology,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
A case of tardive dystonia associated with long-acting injectable paliperidone palmitate.
July 2016, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study.
January 2019, Journal of clinical psychopharmacology,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia.
August 2021, The Australian and New Zealand journal of psychiatry,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety.
May 2017, Psychopharmacology bulletin,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?
July 2018, Psychological medicine,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Long-acting injectable paliperidone palmitate induced severe cutaneous allergic reaction in a patient with first episode delusional disorder tolerating oral paliperidone regimen: a case report.
November 2022, BMC psychiatry,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
A stitch in time: 3-monthly long-acting injectable paliperidone palmitate in schizophrenia.
October 2017, Therapeutic advances in psychopharmacology,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia.
February 2012, The international journal of neuropsychopharmacology,
Erdinc Cicek, and Ismet Esra Cicek, and Faruk Uguz
Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models.
March 2024, bioRxiv : the preprint server for biology,
Copied contents to your clipboard!